使用CVIC工具估算加纳COVID-19疫苗部署与引入的成本
BACKGROUND: This study estimated cost of COVID-19 vaccine introduction and deployment in Ghana. METHODS: Using the WHO-UNICEF COVID-19 Vaccine Introduction and deployment Costing (CVIC) tool Ghana's Ministry of Health Technical Working Group for Health Technology Assessment (TWG-…
要点
- 完成基础免疫每人成本20.9至26.2美元,每剂10.5至13.1美元(含疫苗成本)。
- 疫苗剂量(含运输)占总成本78%至83%,为最大成本驱动。
核心结论
- 研究提供了COVID-19疫苗引入与部署的成本估算,供政府及其他伙伴动员资源参考。
研究设计与样本
- 加纳卫生部卫生技术评估技术工作组与加纳大学公共卫生学院合作,使用WHO-UNICEF CVIC工具,通过初始为期两天的研讨会与后续2-3天验证确定输入参数,分析三种情景:情景1为AstraZeneca(40%)、Johnson & Johnson(30%)、Moderna、Pfizer和Sputnik V各10%,基础免疫于2021年下半年完成;情景2为AstraZeneca(30%)、Johnson & Johnson(40%)、Moderna、Pfizer和Sputnik V各10%,基础免疫于2022年上半年完成;情景3为五种疫苗各20%,基础免疫于2022年下半年完成。
主要发现
- 完成基础免疫每人成本为20.9至26.2美元,每剂成本(含疫苗成本)为10.5至13.1美元。
- 完成基础免疫每人成本(不含疫苗成本)为4.5至4.6美元,每剂成本(不含疫苗成本)为2.2至2.3美元。
- 主要成本驱动为疫苗剂量(含运输),占总成本的78%至83%。
- 2021-2022年预计需要8437至10247名非全职等效(non-FTE)接种人员,采用混合配送策略,接种人员成本占总成本的8%至10%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study estimated cost of COVID-19 vaccine introduction and deployment in Ghana. METHODS: Using the WHO-UNICEF COVID-19 Vaccine Introduction and deployment Costing (CVIC) tool Ghana's Ministry of Health Technical Working Group for Health Technology Assessment (TWG-HTA) in collaboration with School of Public Health, University of Ghana, organized an initial two-day workshop that brought together partners to deliberate and agree on input parameters to populate the CVIC tool. A further 2-3 days validation with the Expanded Program of Immunization (EPI) and other partners to finalize the analysis was done. Three scenarios, with different combinations of vaccine products and delivery modalities, as well as time period were analyzed. The scenarios included AstraZeneca (40%), Johnson & Johnson (J&J) (30%), Moderna, Pfizer, and Sputnik V at 10% each; with primary schedule completed by second half of 2021 (Scenario 1); AstraZeneca (30%), J&J (40%), Moderna, Pfizer, and Sputnik V at 10% each with primary schedule completed by first half of 2022 (Scenario 2); and equal distribution (20%) among AstraZeneca, J&J, Moderna, Pfizer, and Sputnik V with primary schedule completed by second half of 2022 (Scenario 3). RESULTS: The estimated total cost of COVID-19 vaccination ranges between $348.7 and $436.1 million for the target population of 17.5 million. These translate into per person completed primary schedule cost of $20.9-$26.2 and per dose (including vaccine cost) of $10.5-$13.1. Again, per person completed primary schedule excluding vaccine cost was $4.5 and $4.6, thus per dose excluding vaccine also ranged from $2.2 - $2.3. The main cost driver was vaccine doses, including shipping, which accounts for between 78% and 83% of total cost. Further, an estimated 8,437-10,247 vaccinators (non-FTEs) would be required during 2021-2022 to vaccinate using a mix of delivery strategies, accounting for 8-10% of total cost. CONCLUSION: These findings provide the estimates to inform resource mobilization efforts by government and other partners.
引用
- Nonvignon J, Owusu R, Asare B, et al. Estimating the cost of COVID-19 vaccine deployment and introduction in Ghana using the CVIC tool. Vaccine. 2022. PMID: 35190206. doi:10.1016/j.vaccine.2022.01.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。